These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 16686924)

  • 41. Regulation of Regenerative Medicine Products.
    Gee AP
    Adv Exp Med Biol; 2018; 1098():189-198. PubMed ID: 30238372
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Medical devices and the US Food and Drug Administration: regulating the tools of radiology.
    Henderson JA; Smith JJ
    J Am Coll Radiol; 2005 Jun; 2(6):504-10. PubMed ID: 17411867
    [TBL] [Abstract][Full Text] [Related]  

  • 43. American Society for Artificial Internal Organs: the government's role in advancing regenerative medicine and tissue engineering.
    Zucker HA
    ASAIO J; 2004; 50(6):xix-xxi. PubMed ID: 15672773
    [No Abstract]   [Full Text] [Related]  

  • 44. Overview of the clinical application of regenerative medicine products in Japan.
    Tsubouchi M; Matsui S; Banno Y; Kurokawa K; Kawakami K
    Health Policy; 2008 Oct; 88(1):62-72. PubMed ID: 18395290
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The challenge to global acceptance of Part 3 of ISO 10993.
    Carraway J; Ghosh C
    Med Device Technol; 2006 Jun; 17(5):16-8. PubMed ID: 16903383
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A turbulent year at the agency.
    Ratner M
    Nat Biotechnol; 2006 Feb; 24(2):145-51. PubMed ID: 16465153
    [No Abstract]   [Full Text] [Related]  

  • 47. Globalization of cosmetic regulations.
    Blaschke JW
    Food Drug Law J; 2005; 60(3):413-9. PubMed ID: 16304748
    [No Abstract]   [Full Text] [Related]  

  • 48. Food fight: making sure our food is safe is harder than it seems.
    Farquhar D
    State Legis; 2007; 33(9):26-8. PubMed ID: 17972415
    [No Abstract]   [Full Text] [Related]  

  • 49. How allograft tissue is regulated.
    OR Manager; 2010 Dec; 26(12):17. PubMed ID: 21250562
    [No Abstract]   [Full Text] [Related]  

  • 50. Answering the bell again.
    Med Prod Sales; 1983 Mar; 14(3):50-2. PubMed ID: 10258846
    [No Abstract]   [Full Text] [Related]  

  • 51. The long journey from stem cells to medical product.
    Parson A
    Cell; 2006 Apr; 125(1):9-11. PubMed ID: 16615881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Kava: a supplement to avoid.
    Consum Rep; 2003 Mar; 68(3):8. PubMed ID: 12599340
    [No Abstract]   [Full Text] [Related]  

  • 53. Vioxx, radiology, and the Food and Drug Administration.
    Pentecost MJ
    J Am Coll Radiol; 2005 May; 2(5):394-7. PubMed ID: 17411841
    [No Abstract]   [Full Text] [Related]  

  • 54. Changes in European legislation make it timely to introduce a transparent market surveillance system for cosmetics.
    Lodén M; Ungerth L; Serup J
    Acta Derm Venereol; 2007; 87(6):485-92. PubMed ID: 17989885
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Overhaul US licensing process for devices, urges Institute of Medicine.
    Cohen D
    BMJ; 2011 Aug; 343():d4990. PubMed ID: 21810870
    [No Abstract]   [Full Text] [Related]  

  • 56. Is it a cosmetic, a drug, or both? (Or is it soap?).
    Center for Safety and Applied Nutrition/Office of Cosmetics and Colors US Food and Drug Administration
    Plast Surg Nurs; 2008; 28(4):195-7. PubMed ID: 19092587
    [No Abstract]   [Full Text] [Related]  

  • 57. Medical device recalls from 2004 to 2006: a focus on Class I recalls.
    Villarraga ML; Guerin HL; Lam T
    Food Drug Law J; 2007; 62(3):581-92. PubMed ID: 17915400
    [No Abstract]   [Full Text] [Related]  

  • 58. Truth in testing laws: a shot in the arm for designer gene tests.
    van Voorhees A
    Health Matrix Clevel; 2006; 16(2):797-829. PubMed ID: 16948256
    [No Abstract]   [Full Text] [Related]  

  • 59. Legal requirements for the quality of herbal substances and herbal preparations for the manufacturing of herbal medicinal products in the European union.
    Vlietinck A; Pieters L; Apers S
    Planta Med; 2009 Jun; 75(7):683-8. PubMed ID: 19204891
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA challenges stem-cell clinic.
    Cyranoski D
    Nature; 2010 Aug; 466(7309):909. PubMed ID: 20725009
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.